136 related articles for article (PubMed ID: 27725294)
21. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
[TBL] [Abstract][Full Text] [Related]
22. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
24. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
Mar-Aguilar F; Luna-Aguirre CM; Moreno-Rocha JC; Araiza-Chávez J; Trevino V; Rodríguez-Padilla C; Reséndez-Pérez D
Asia Pac J Clin Oncol; 2013 Mar; 9(1):53-9. PubMed ID: 22898264
[TBL] [Abstract][Full Text] [Related]
28. miR-21: A gene of dual regulation in breast cancer.
Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of MiR-21 and MiR-10b Expression of Human Breast Cancer in West Sumatera.
Yanwirasti ; A Harahap W; Arisanty D
Pak J Biol Sci; 2017; 20(4):189-196. PubMed ID: 29023075
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of miR-1297, miR-3191-5p, miR-4435, and miR-4465 in malignant and benign breast tumors.
Mosapour A; Karami Tehrani FS; Atri M
Iran J Basic Med Sci; 2020 Aug; 23(8):1045-1052. PubMed ID: 32952951
[TBL] [Abstract][Full Text] [Related]
31. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
[TBL] [Abstract][Full Text] [Related]
35. Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
Petrovic N; Davidovic R; Jovanovic-Cupic S; Krajnovic M; Lukic S; Petrovic M; Roganovic J
Mol Diagn Ther; 2016 Dec; 20(6):603-615. PubMed ID: 27488105
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
37. Expression and polymorphism of micro-RNA according to body mass index and breast cancer presentation in Tunisian patients.
Belaiba F; Medimegh I; Ammar M; Jemni F; Mezlini A; Romdhane KB; Cherni L; Benammar Elgaaïed A
J Leukoc Biol; 2019 Feb; 105(2):317-327. PubMed ID: 30303554
[TBL] [Abstract][Full Text] [Related]
38. Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent radiosensitivity.
Rajabi F; Mozdarani H
Exp Mol Pathol; 2022 Jun; 126():104758. PubMed ID: 35337805
[TBL] [Abstract][Full Text] [Related]
39. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
40. The expression of miRNA-152-3p and miRNA-185 in tumor tissues versus margin tissues of patients with chemo-treated breast cancer.
Safi A; Delgir S; Ilkhani K; Samei A; Mousavi SR; Zeynali-Khasraghi Z; Bastami M; Alivand MR
BMC Res Notes; 2021 Jun; 14(1):234. PubMed ID: 34134782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]